Dice CEO: Energy, T...
Health Care: Drugs
Auxilium Pharmaceuticals Inc. (AUXL: NASDAQ)
$18.85 -0.25 | -1.31%
06/01/12 - 04:00 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | n.a. | 37.90 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | 51.70 | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | 14.70 | 12.50 |
| Beta | 0.70 | 1.00 | 0.98 |
| Price to Sales (TTM) | 3.26 | 3.03 | 1.42 |
| Price to Book (MRQ) | 10.29 | 6.84 | 2.41 |
| Price to Tangible Book (MRQ) | 10.29 | 17.79 | 5.08 |
| Price to Cash Flow (TTM) | -64.40 | 27.00 | 9.80 |
| Price to Free Cash Flow (TTM) | 31.70 | 81.90 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 0.70 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 0.70 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | 28.81 | -0.76 |
| Payout Ratio (TTM) | 0.00 | 13.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 26.10 | 14.20 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | 25.00 | -22.20 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 28.47 | 6.76 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | n.a. | 35.40 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | n.a. | 35.40 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | 18.45 | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | 31.17 | 8.20 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 2.30 | 1.20 | 1.10 |
| Current Ratio (MRQ) | 2.90 | 2.20 | 1.60 |
| LT Debt to Equity (MRQ) | 0.00 | 0.40 | 0.82 |
| Total Debt to Equity (MRQ) | 0.00 | 0.47 | 0.96 |
| Interest Coverage (TTM) | n.a. | 13.40 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 81.30 | 64.70 | 46.90 |
| Gross Margin - 5 Yr Avg | 79.70 | 58.30 | 47.70 |
| EBITD Margin (TTM) | -5.20 | 17.70 | 18.90 |
| EBITD - 5 Yr Avg | -38.41 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | -8.20 | 13.60 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | -26.10 | 9.40 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | -0.08 | 0.10 | 0.09 |
| Net Profit Margin - 5 Yr Avg | -26.10 | 6.00 | 7.00 |
| Return on Assets (TTM) | -7.30 | 7.60 | 3.10 |
| Return on Assets - 5 Yr Avg | -20.70 | 6.30 | 2.50 |
| Return on Investment (TTM) | -25.00 | 10.60 | 7.90 |
| Return on Investment - 5 Yr Avg | -56.30 | 8.90 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 527,457.00 | 213,744.00 | 449,376.00 |
| Net Income/Employee (TTM) | -43,053.00 | 20,301.00 | 39,003.00 |
| Receivable Turnover (TTM) | 6.70 | 8.40 | 7.60 |
| Inventory Turnover (TTM) | 1.10 | 1.80 | 8.30 |
| Asset Turnover (TTM) | 1.00 | 0.80 | 0.40 |
Portfolios with AUXL
- Portfolio NameUser Type
- Contributor22 Biopharma Stocks With Br...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Userinsider buying
- ContributorBarron's Summary 6-26-2010
- ContributorBarron's Research Reports 9...
- UserTrader Doug
- Userkiwiloz
- UserBarron's Summary 8-09-2008
- UserEd Mahaffey Portfolio - Ble...
Latest AUXL Headlines from TheStreet
- Stocks Under $10: Healthcare Name on Sale
05.17.12 | 07:05 am - 8 Stocks Ripping Higher on Big Volume 05.11.12 | 01:05 pm
- BioSante: A Penny Stock Still Overvalued 02.16.12 | 07:02 am
- UBS: 6 Specialty Pharma Picks to Watch 01.21.12 | 07:01 am
- Stocks to Watch as Earning Season Kicks off with Alcoa 01.09.12 | 08:01 am
- 7 Stocks Rising on Huge Volume 12.08.11 | 12:12 pm
- Auxilium Pharmaceuticals Inc. (AUXL): Today's Featured Health Care Winner 11.16.11 | 05:11 pm
- Auxilium Stock Hits New 52-Week Low (AUXL) 08.08.11 | 10:08 am
- Insiders Trading MLI, AMCX, TXI, AUXL 08.04.11 | 10:08 am
- Auxilium Stock Falls On Unusually High Volume (AUXL) 08.01.11 | 03:08 pm
Press Releases for AUXL
- Auxilium Pharmaceuticals, Inc. And FCB I LLC Receive Paragraph IV Certification Notice From Watson Laboratories, Inc. For Testim® - PR Newswire 04.16.12 | 04:04 pm
- BioSpecifics Announces Partnership Between Auxilium And Actelion For XIAFLEX® In Canada, Australia, Brazil And Mexico - PR Newswire 02.23.12 | 04:02 pm
- Auxilium Pharmaceuticals, Inc. And Actelion Pharmaceuticals Ltd. Enter A Collaboration Agreement For XIAFLEX® In Canada, Australia, Brazil And Mexico - PR Newswire 02.23.12 | 01:02 am
- Auxilium Announces Appointments To Enhance Leadership Team - PR Newswire 02.06.12 | 09:02 am
- Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed In XIAFLEX® Phase Ib Cellulite Study - PR Newswire 01.26.12 | 07:01 am
- Auxilium Pharmaceuticals, Inc. Appoints Adrian Adams Chief Executive Officer And President - PR Newswire 12.08.11 | 07:12 am
- Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed In XIAFLEX® Study For Frozen Shoulder Syndrome - PR Newswire 12.01.11 | 07:12 am
- Auxilium Pharmaceuticals To Present At The Oppenheimer 22nd Annual Healthcare Conference - PR Newswire 11.28.11 | 07:11 am
- TRiUS Data Suggests That Testim® Significantly Improved Sexual Function In Hypogonadal Men - PR Newswire 11.03.11 | 07:11 am
- Auxilium Pharmaceuticals Announces Hypogonadism Awareness Ad Campaign Wins Medical Marketing & Media Award - PR Newswire 10.13.11 | 07:10 am
Partner Headlines for AUXL
- Healthcare Biz Recap: Express Scripts New Driver, Elan Pops - Wall St. Cheat Sheet 05.27.12 | 12:05 pm
- Auxilium-Glaxo to Drive Testim Sales - Analyst Blog - Zacks 05.22.12 | 10:05 am
- Loss Narrows at Auxilium - Analyst Blog - Zacks 05.14.12 | 10:05 am
- Auxilium Misses 4Q Estimates - Analyst Blog - Zacks 02.27.12 | 10:02 am
- 10 Overvalued Healthcare Stocks - Seeking Alpha 10.25.11 | 08:10 am
- Auxilium Outlines Xiaflex Plans - Analyst Blog - Zacks 09.02.11 | 05:09 pm
- AUXL Cuts View Despite Lower Loss - Analyst Blog - Zacks 08.09.11 | 06:08 pm
- Friday Options Recap - Seeking Alpha 06.24.11 | 04:06 pm
- Strong YTD Insider Buying at These Billion Dollar Companies - Seeking Alpha 06.10.11 | 07:06 am
- Contrarian Ideas: 25 High Growth Stocks With Significant Short Selling - Seeking Alpha 06.06.11 | 08:06 am
